Skip to main content
OpenTrials
Completed

NCT Number: NCT01179412

Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Department of Ophthalmology, Siriraj Hospital Mahidol University

Bangkoknoi, Bangkok, 10700, Thailand

About this study

The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who were diagnosed with EKC at the outpatient ophthalmic unit

Exclusion criteria

  • children younger than six years
  • women being pregnant or during lactation
  • history of allergy to povidone-iodine
  • prior ocular surgery
  • contact lens usage and chronic eye diseases with current eye medications.

Treatment and study plan

2% povidone-iodine

Drug

apply 4 times a day for one week

Other names: PVP-I

Primary outcomes

  1. the recovery rate within one week of treatment

    Time frame: 1 week

Secondary outcomes

  1. drug tolerability

    Time frame: 1 week

    proportion of patient who can continue topical application of povidone-iodine for a week or until EKC subsides

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Important dates

Study start
2004
Primary completion
2009
Study completion
2009
First posted
Aug 11, 2010
Registry last updated
Aug 11, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.